SG Americas Securities’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $97K | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $217K | Sell |
|
|||||
|
2024
Q4 | $374K | Buy |
|
|||||
|
2024
Q3 | $157K | Buy |
|
|||||
|
2024
Q2 | $57K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $2.86M | Buy |
|
|||||
|
2023
Q3 | $1.76M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $269K | Buy |
|
|||||
|
2022
Q4 | $158K | Buy |
|
|||||
|
2022
Q3 | $149K | Sell |
|
|||||
|
2022
Q2 | $335K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $218K | Sell |
|
|||||
|
2021
Q3 | $452K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $156K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $69K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $62K | Buy |
|